Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

US Patent 11402391 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of assaying neoplastic and neoplasia-related cells and uses thereof2025
Methods of assigning a COVID pathological type based on a cytokine/chemokine pan2025
Methods of assigning a COVID pathological type based on a cytokine/chemokine pan2025
Methods of assigning a COVID pathological type based on a cytokine/chemokine pan2025
Methods of assigning a COVID pathological type based on a cytokine/chemokine pan2025
Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) inte2024
Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) inte2024
Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) inte2024
Methods of assaying neoplastic and neoplasia-related cells and uses thereof2023
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a hum2023
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a hum2023
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a hum2023